Table 3. All-grade treatment-related AEs: SAS cluster.
| AEs | TACE (N=20) | |
|---|---|---|
| Grade 1–2 | ≥ Grade 3 | |
| All adverse reactions | 19 [95] | 1 [5] |
| Nausea and vomiting | 7 [35] | 0 |
| Dull pain in upper abdominal liver region | 6 [30] | 1 [5] |
| Right upper abdominal distension and pain | 5 [25] | 0 |
| Epigastric pain | 3 [15] | 0 |
| Stomachache | 3 [15] | 0 |
| Slight fever | 2 [10] | 0 |
| Fatigue | 2 [10] | 0 |
| Dizziness | 1 [5] | 0 |
| Upper abdominal pain | 1 [5] | 0 |
| Polypnea | 1 [5] | 0 |
| Pain and swelling under the xiphoid process | 1 [5] | 0 |
Data are presented as n [%]. AEs, adverse events; SAS, safety analysis set; TACE, transarterial chemoembolization.